156 results
Antiplatelet Medications - Summary Table

Aspirin - Inhibits cyclooxygenase, preventing formation of thromboxane A2
 • Acute coronary
Medications - Summary Table ... Aspirin - Inhibits ... ticagrelor) - Inhibits ... (and PDE3 inhibition ... Medications #Summary #Table
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Between P2Y12 Inhibitors ... Oral P2Y12 inhibitors ... Switching P2Y12 inhibitors ... - Escalation ... Ticagrelor - De-escalation
Angiotensin-Converting Enzyme Inhibitors - Inhibit the conversion of AngI to AngII
 • Captopril, Lisinopril, Enalapril, Benazepril,
Angiotensin-Converting Enzyme Inhibitors ... - Inhibit the conversion ... Direct Renin Inhibitors ... - Inhibit renin ... #pharmacology #table
Summary of characteristics of Platelet Aggregation Inhibitors

#AntiPlatelet #Inhibitors #Pharmacology #Table #Overview #Interactions #Pharmacology #Cardiology
Platelet Aggregation Inhibitors ... #AntiPlatelet #Inhibitors ... #Pharmacology #Table
Summary of Diuretic Agents 
Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction
CARBONIC ANHYDRASE
CARBONIC ANHYDRASE INHIBITORS ... others SGLT2 INHIBITORS ... Pharmacology #summary #table ... #nephrology
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Summary table of ... Selective factor Xa inhibitors ... thrombin (factor lla) inhibitors ... doac #comparison #table
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Between Oral P2Y12 Inhibitors ... patients who are deescalating ... *Consider de-escalation ... De-escalation from ... .117.031164 #P2Y12 #Inhibitor
Indications for and pharmacological properties of approved SGLT2 inhibitors

Canagliflozin - Dapagliflozin - Empagliflozin - Ertugliflozin

#SGLT2 #Inhibitors
approved SGLT2 inhibitors ... Ertugliflozin #SGLT2 #Inhibitors ... #pharmacology #table
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... events TZDs DPP-4 inhibitors ... SGLT2 inhibitors ... #medications #table
Allopurinol and its active metabolite inhibit xanthine oxidase, the enzyme that converts hypoxanthine to xanthine and
active metabolite inhibit ... Inhibition of this ... druginformation #nephrology